Hydrix has a 20+ year track record in developing FDA Class II & III medical devices, implanted devices, wearables, and diagnostic & life sciences instruments. Ahead of AACC, our insights team spoke to POC developers on their challenges post the COVID-19 pandemic.
We learned of challenges in strategy, resourcing & budgets, and a need for new revenue sources for newly developed platforms. Hydrix has developed a ‘drag and drop’ to approach help with these challenges. Visit our booth to learn more!